Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with osteoarthritis and rheumatoid arthritis [1]. It works by reducing hormones that cause inflammation and pain in the body [2].
What is Meloxicam prescribed for?
Meloxicam is primarily prescribed for the management of pain and swelling in conditions like osteoarthritis and rheumatoid arthritis [1]. It is available in oral tablet and liquid forms [2].
How does Meloxicam work?
Meloxicam belongs to a class of drugs called NSAIDs. It functions by inhibiting cyclooxygenase (COX) enzymes, specifically COX-2 to a greater extent than COX-1. This inhibition reduces the production of prostaglandins, which are chemicals in the body that trigger inflammation, pain, and fever [3].
When does Meloxicam patent exclusivity end?
The patent exclusivity for meloxicam has expired. This means that generic versions of the drug are available [4]. DrugPatentWatch.com tracks patent expirations for pharmaceuticals, and for meloxicam, these protections have lapsed, allowing for generic competition [4].
What are the common side effects of Meloxicam?
Common side effects of meloxicam can include stomach pain, nausea, diarrhea, dizziness, and headache [2]. More serious side effects, though less common, can involve gastrointestinal bleeding, heart attack, stroke, and kidney problems. Patients should seek medical attention if they experience severe stomach pain, black or bloody stools, or chest pain [2][3].
Are there alternatives to Meloxicam for arthritis pain?
Yes, several alternatives exist for managing arthritis pain. Other NSAIDs, such as ibuprofen and naproxen, are commonly used. Acetaminophen is another option for pain relief. For more severe cases, disease-modifying antirheumatic drugs (DMARDs) or biologic agents may be prescribed, particularly for rheumatoid arthritis [5].
How does Meloxicam compare to other NSAIDs?
Meloxicam is considered a COX-2 selective NSAID, meaning it preferentially inhibits the COX-2 enzyme over COX-1. This selectivity may result in a lower risk of gastrointestinal side effects compared to non-selective NSAIDs, although the risk is not entirely eliminated [3]. However, the increased COX-2 selectivity of meloxicam compared to some other NSAIDs has also been linked to a potential increased risk of cardiovascular events in some studies [3].
Can generic Meloxicam be made before patent expiry?
Generally, generic versions of a drug cannot be legally marketed until the relevant patents and exclusivity periods have expired. This is to allow the innovator company to recoup its research and development costs. Once patents expire, other companies can manufacture and sell generic versions, often at a lower cost [4].
Who manufactures generic Meloxicam?
Following the patent expiry of branded meloxicam (e.g., Mobic), numerous pharmaceutical companies have entered the market with their own generic versions. These manufacturers include companies like Teva Pharmaceuticals, Mylan, and others [6].
Sources:
[1] https://www.drugpatentwatch.com/drugs/meloxicam
[2] https://www.nhs.uk/medicines/meloxicam/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285483/
[4] https://www.drugpatentwatch.com/drugs/meloxicam
[5] https://www.mayoclinic.org/diseases-conditions/arthritis/diagnosis-treatment/drc-20350109
[6] https://www.drugpatentwatch.com/drugs/meloxicam/generics